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Abstract This study investigated whether molecules
spontaneously transported inside cells, like glucose deriv-
atives, can also be used as electropermeabilization markers.
Uptake of a fluorescent deoxyglucose derivative (2-NBDG)
by normal and electropermeabilized cells in culture was
analyzed. 2-NBDG was added to DC-3F cell suspensions
and cells, exposed or not to eight square-wave electric
pulses of 100-ls duration and of appropriate field ampli-
tude at a repetition frequency of 1 Hz or 5 kHz, were
incubated at 37 C. 2-NBDG uptake was temperature-,
concentration- and time-dependent in cells submitted or not
to the electric pulses. In spite of significant uptake of
2-NBDG mediated by GLUT transporters into nonper-
meabilized cells, the electric pulses significantly increased
about ten to hundred times the 2-NBDG uptake into the
cells. The increase in the field amplitude from 900 to
1,500 V/cm resulted in a progressive increase of 2-NDBG.
Our results show that under the conditions of in vivo
exposure duration to FDG and the physiological concen-
tration of D-glucose, electric pulses increased 2-NBDG
uptake into electropermeabilized cells. Under our experi-
mental conditions, the percentage of permeabilized cells
within the population of cells exposed to electric pulses
remained at the same level regardless of the pulse fre-
quency used, 1 Hz or 5 kHz. The findings showed that
glucose derivatives can also be used to detect electroper-
meabilized cells exposed to electric pulses.
Keywords 2-NBDG  FDG  PET scan 
Electropermeabilization  Flow cytometry  Tumor cell
Introduction
Cell electropermeabilization or electroporation is a physical
method that uses short and intense electric pulses to increase
cell membrane permeability (Neumann et al. 1982) and,
therefore, increase the uptake of molecules such as DNA,
antibodies and oligonucleotides into the cells (Mir 2001).
Electroporation can also facilitate the crossing of the
cell membrane and the cellular uptake of drugs, for mol-
ecules that are hydrophilic and lack transport systems or for
low-permeant molecules that poorly cross the plasma
membrane (Orlowski et al. 1988; Sersa et al. 2003; Silve
and Mir 2011). Several chemotherapeutic drugs were tested
in vitro for potential application in combination with cell
electroporation, and an increase of thousands of times was
demonstrated for bleomycin and one of several times for
cisplatin (Melvik et al. 1986; Orlowski et al. 1988; Sersa
et al. 1995; Kambe et al. 1996; Cemazar et al. 1998, 2001;
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Gehl et al. 1998; Jaroszeski et al. 2000; Kuriyama et al.
2000; Breton and Mir 2012). Therefore, the selection is
limited to those drugs that are hydrophilic and lack trans-
port systems in the membrane.
To monitor in vitro the permeability of cells, classical
approaches rely on the uptake of fluorescence markers such
as Lucifer yellow (Mir et al. 1988) and propidium iodide
(Djuzenova et al. 1996) or on the release of previously
loaded fluorescent markers, all of them being nonpermeant
molecules that cannot diffuse through the membrane of
intact cells (Silve and Mir 2011).
Glucose is a permeant molecule taken up by cells
through different glucose transporters that specifically
internalize the glucose molecules. Once in the cells, glu-
cose is phosphorylated by the hexose kinases and the
phosphorylated molecules cannot be transported back to
the extracellular medium. We analyzed whether glucose
derivatives can be used to detect cell electropermeabiliza-
tion. Indeed, our final purpose was to evaluate whether
18F-fluorodeoxyglucose (FDG), a radioactive glucose
derivative used for clinical investigations and for diagnosis,
staging and monitoring of the treatment of cancers by
positron emission tomography (PET) (Hoh et al. 1993;
Bomanji et al. 2001; Reske and Kotzerke 2001; Chin and
Chang 2006), could have the potential for imaging per-
meabilized cells and mapping electropermeabilized tissues
in vivo by PET. To survey the ability of FDG PET for
monitoring the efficacy of electric pulses in experiments in
vivo, the first mandatory step was to establish the feasi-
bility of this approach in in vitro studies.
Because of limitations to the use of FDG in vitro, like
the very short half-time of 18Fluor, the need for protection
in wet labs and the high cost, the use of this molecule is not
easy to implement. Fluorescence-labeled deoxyglucose
molecules (like 2-NDBG) can replace radioactive glucose
derivatives (Nitin et al. 2009). 2-NBDG has been used to
evaluate glucose metabolism in different model systems
like Escherichia coli (Natarajan and Srienc 1999), yeast
(Oh and Matsuoka 2002), pancreatic islet cells and neurons
(Itoh et al. 2004) as well as in various cancer cell lines
(O’Neil et al. 2005; Cheng et al. 2006). As 2-NBDG is a
fluorescent analogue of D-glucose, it is transported like
FDG into cells by glucose transporters (GLUTs), which are
located at the cell membrane and cause facilitated transport
of glucose across the membrane (Yoshioka et al. 1996a,
1996b, 1996c; Lloyd et al. 1999; Yamada et al. 2000;
Zhang et al. 2004; Cheng et al. 2006; Iori et al. 2006; Nitin
et al. 2009). Although six isoforms (GLUT1–GLUT5 and
GLUT7) of these transporters have been identified
(Pauwels et al. 2000), 2-NBDG is incorporated into the
pancreatic ß-cells through GLUT1 and GLUT2 (Yamada
et al. 2000). GLUT1 is widely expressed in cancer cells
(Younes et al. 1996) such as MCF-7 and HepG2 cells
(Chen et al. 2002). Consequently, 2-NBDG uptake in
tumor cells should be facilitated by this glucose trans-
porter (O’Neil et al. 2005). Therefore, there is spontaneous
uptake of 2-NBDG in the absence of any cell membrane
permeabilization. As electroporation-based therapies, like
electrochemotherapy (ECT), are based on the increase of
drug uptake into tumor cells caused by transient perme-
abilization of the cell membrane, we studied the effect of
electric pulses on the uptake of 2-NBDG in DC-3F cells. In
particular, we explored whether the uptake by transiently
electropermeabilized cells could be larger than the spon-
taneous uptake for a period of time compatible with those
of the usual PET investigations.
Materials and Methods
Cells
DC-3F cells are spontaneously transformed Chinese ham-
ster fibroblasts (Biedler and Riehm 1970). They were
grown in minimum essential medium (SMEM) supplement
with 10 % fetal bovine serum (FBS) and 1 % penicillin/
streptomycin solution (all from Life Technologies, Carls-
bad, CA). Cells were detached with trypsin/EDTA (life
technologies), counted and seeded in new flasks using
standard protocols.
Cell Electropermeabilization
After trypsinization, cells were centrifuged for 10 min at
1,000 rpm at 4 C and suspended in phosphate-buffered
saline (PBS) to obtain 5 9 105 cells per 45 ll (*107 cells/
ml). For each experiment, 5 ll of NBDG (MW 342.26)
(Molecular Probes, Eugene, OR) were added to the 45 ll of
cell suspension. Immediately after, the 50 ll of cells in the
presence of NBDG were placed in a sterile electroporation
cuvette (Cell Projects, Kent UK; with a 1-mm gap between
the electrodes). Eight square-wave electric pulses of
appropriate voltage and of 100-ls duration were delivered
at a repetition frequency of 1 Hz or 5 kHz using a Clini-
porator (IGEA, Carpi, Italy).
In competition experiments, after trypsinization, cells
were suspended in PBS containing 5.5, 11 or 27.5 mM
D-glucose (Merck, Darmstadt, Germany). All experiments
were performed at 22 or 37 C as explained in the text.
Flow Cytometry
In all experiments, 2-NBDG uptake was stopped by dilut-
ing the cells with 15 ml of precooled PBS. Cells were
subsequently resuspended in 500 ll precooled PBS and
maintained at 4 C before flow cytometric analysis.
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For each measurement, fluorescence was measured with
a FACScan flow cytometer (Becton Dickinson Immuno-
cytometry Systems, San Jose, CA). Cells were excited at
488 nm, and the emitted 2-NBDG fluorescence was col-
lected at 640 nm. Data from each flow cytometric mea-
surement (relative scatter light or fluorescence intensity of
each event) were stored under flow cytometry standard
format. Controls (no 2-NBDG and no pulse in the presence
of 2-NBDG) were included in all experiments.
Data Processing
All experiments were repeated at least three times on dif-
ferent days. Results are presented as the relative difference
in the peak channel of the fluorescence intensity between
each group and the corresponding control performed in the
same experiment. Results are also presented as the per-
centage of events in the most fluorescent part of the cell
population exposed to 2-NBDG and to the electric pulses
(which should correspond to the percentage of reversibly
permeabilized cells detected by 2-NBDG uptake). ANOVA
and paired Student’s t-test were used to evaluate the sta-
tistical significance of differences between the experimental
and control groups. p \ 0.05 was considered significant.
Results
Temperature Dependence of 2-NBDG Uptake
As spontaneous uptake is mediated by the activity of glucose
transporters, we first analyzed the uptake temperature
dependence with and without pulses, using typical electrical
parameters for the reversible electropermeabilization of
DC-3F cells (eight electric pulses of 1,200 V/cm and 100-ls
duration delivered at a repetition frequency of 1 Hz). Cells
were put in the presence of 300 lM 2-NBDG, immediately
subjected to electric pulses (or not in the controls) and
incubated for 5 more min at 22 or 37 C (Table 1). Uptake of
2-NBDG was sensitive to temperature. In nonelectroporated
cells, 2-NBDG uptake was larger at 37 C than at 22 C
(Table 1). This difference was significant (p \ 0.01). In
samples treated with electric pulses a large increase in
2-NBDG uptake was observed for incubations of just 5 min,
the time for the cells to reseal according to previous expe-
rience with these cells (Orlowski et al. 1988). Actually, a
biphasic distribution was found, corresponding to the fluo-
rescence of the transiently permeabilized cells and of the
nonpermeabilized cells (in spite of their exposure to the
electric pulses). Uptake in permeabilized cells was much
more important than that in nonpermeabilized cells. More-
over, fluorescence was significantly (p \ 0.001) higher at
37 C with respect to uptake at 22 C (mean peak channel
increased from 2,951 to 3,918). Because in all cases uptake at
37 C was higher than at 22 C and since 37 C is close to the
physiological body temperature in most mammals, it was
decided that all further experiments would be performed at
37 C.
It must also be noted that at 22 C 2-NBDG uptake was
very low as there was almost no increase in cell fluores-
cence compared to the autofluorescence of those cells
(Table 1, Fig. 1). At 37 C, a net increase in fluorescence
was found, which was the consequence of the increase in
the cell basal metabolism as a result of exposure of cells at
37 C physiological temperature.
2-NBDG Uptake Dependence on Its Concentration
To assess the optimal 2-NBDG concentration to be used in
further experiments, cells were incubated in the presence of
10, 20, 40, 80, 160, 240 and 300 lM of 2-NBDG for 10 min
after applying electric pulses at zero (controls no pulse),
1,000 or 1,200 V/cm (Fig. 2). In all cases, cell fluorescence
increased with respect to the controls incubated in the
absence of 2-NBDG (p \ 0.001). In samples exposed to
electric pulses, there was a large increase in uptake
(p \ 0.001), by two orders of magnitude, in electroper-
meabilized cells (Fig. 2). The highest 2-NBDG uptake was
obtained at 300 lM, but the working concentration of
240 lM was chosen because the percentage of events in the
part of the cell population that was electropermeabilized
was higher in the presence of 240 lM 2-NBDG (data not
Table 1 Effect of electric pulses on uptake of 2-NBDG at an external concentration of 300 lM
Group Peak channel of M1 or M2 region (means ± SD)
22 (C) 37 (C) 37/22 (C)
No 2-NBDG (Autofluorescence) 18 ± 8 18 ± 8 1.0
2-NBDG alone 47 ± 30 76 ± 1.5a 1.6
2-NBDG ? electric pulses 2,952 ± 501 3,918 ± 104a 1.3
The changes in the value of the peak channel of the high-fluorescence cell population (M2) are reported in the table. Cells were incubated with
300 lM 2-NBDG for 5 min at room temperature (22 C) or at 37 C and exposed to eight pulses of 100 ls and 1,000 V/cm at a repetition
frequency of 1 Hz
a Difference statistically significant for 2-NBDG uptake at 37 C with respect to 22 C, p \ 0.05
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shown). This could mean that uptake in the presence of
300 lM 2-NBDG is toxic to electropermeabilized cells, and
therefore, this high concentration was not used in sub-
sequent experiments, to avoid such potentially toxic effects.
It can also be noted that uptake with pulses of 1,200 V/cm
was higher than uptake with pulses of 1,000 V/cm and that
at the lowest concentration tested (10 lM 2-NBDG) spon-
taneous uptake by transporters was equally intense as
uptake by electroporation (data not shown). Interestingly, at
concentrations as low as 20 lM, the fluorescence intensity
in samples with pulses was already higher than that in the
corresponding controls: the electric pulses caused an
increased of fluorescence from 12 to 79 and from 8.5 to
117.5 at 1,000 and 1,200 V/cm, respectively (p \ 0.001).
Therefore, the electric pulses moderately enhanced uptake
of 2-NDBG at low concentration (20 lM) and highly
increased it at higher concentrations.
2-NBDG Uptake as a Function of Pulse Amplitude
In the analysis of 2-NBDG uptake as a function of pulse
amplitude, electric pulses with amplitudes of 900; 1,000;
1,100; 1,200; 1,300; 1,400 or 1,500 V/cm were delivered.
Cells were pulsed immediately after the addition of the
fluorescent marker and after the pulses; they were incu-
bated at 37 C for 10 min in a water bath to ensure that
they were incubated at 37 C. Two values were considered:
the percentage of actually permeabilized cells and the peak
channel of their fluorescence, which indicates the level of
2-NBDG uptake by these cells. 2-NBDG uptake increased
with the field amplitude applied (Fig. 3a). Field amplitudes
higher than 1,500 V/cm were not tested as it was known
that they were highly toxic for the cells (induction of
irreversible permeabilization and, thus, of cell death). As
expected, the percentage of events in the population of
cells permeabilized due to electric pulses started to
decrease below this field amplitude (Fig. 3b). The highest
convenient uptake was obtained using electric pulses of
1,200 V/cm, but the maximum percentage of highly fluo-
rescent cells was reached at 1,000 V/cm (p \ 0.01). Thus,
1,000 V/cm was considered to be the optimal electric field
amplitude for the next part of this study.
2-NBDG Uptake in the Presence of D-Glucose
The previous experiments were performed in the absence
of external glucose competing with 2-NBDG uptake. The
effect of the presence of different concentrations of normal
D-glucose on 2-NBDG uptake in DC-3F cells was
Fig. 1 Flow cytometric histograms of DC-3F cells: autofluorescence
(a, b), 2-NBDG alone (c, d) and 2-NBDG together with electric
pulses (e, f) of cells incubated at 22 C (a, c and e) or at 37 C (b,
d and f) during incubation with 2-NBDG (c–f) or without 2-NBDG (a,
b, autofluorescence, control). The effect of eight electric pulses of
100 ls, 1 Hz at 1,200 V/cm on uptake of 2-NBDG was studied (at an
external concentration of 300 lM) into DC-3F cells exposed or not to
the electric pulses
Fig. 2 Changes in the peak channel of monodistributed fluorescent
cells not exposed to the electric pulses or changes in the value of the
peak channel of the high-fluorescence cell population exposed after
electric pulses (eight pulses of 100 ls, 1 Hz at 1,000 or 1,200 V/cm)
in cells. Cells were incubated for 10 min at 37 C. Data are
means ± SD of at least three independent experiments. filled square,
filled circle no electric pulses; filled diamond electric pulses at
1,000 V/cm; filled triangle electric pulses at 1,200 V/cm
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examined to evaluate the potential reduction of fluores-
cence accumulation in the cells, particularly in the presence
of the physiological external concentration of glucose
(5.5 mM). Cells were thus incubated with 240 lM
2-NBDG or with 2-NBDG and 5.5, 11 or 27.5 mM glu-
cose, together with the delivery or not of eight electric
pulses of 100 ls and 1,000 V/cm at a repetition frequency
of 1 Hz. Cells were incubated for 10 min at 37 C after
pulse delivery. Glucose, at all concentrations, affected
2-NBDG uptake by cells that were not exposed to electric
pulses. However, only partial competition was found at
5.5 mM as the fluorescence of only a fraction of the cells
decreased (creating a shoulder in the cell distribution, see
Fig. 4c). However, the peak channel value was not affected
(Fig. 4). At 11 mM, a small majority of the cells showed
reduced fluorescence uptake, while the ‘‘fluorescent’’ cells
remained at the control level. At 27 mM, competition was
complete as even the more ‘‘fluorescent’’ fraction of the
cells showed a decrease in individual fluorescence (peak
channel at a value of 118, significantly different [p \ 0.05]
from the peak channel values of the other groups, at about a
value of 150).
In cells that were treated with the electric pulses in the
presence of different concentrations of external D-glucose,
again there was an increase in uptake by two orders of
magnitude in the part of the cell population exposed to
electric pulses (Fig. 4) (p \ 0.001).
When cells were exposed to electric pulses, the peak
channel value of the highly fluorescent cell population did
not significantly increase in the presence of additional
external D-glucose (p = 0.659 with respect to the control
with no added D-glucose). In addition, the percentage of
events displaying high fluorescence values decreased at
the highest concentrations of D-glucose, 11 or 27.5 mM
(Fig. 5). This could reflect partial competition between
2-NBDG and D-glucose to enter the cells, but the difference
was not statistically significant (p = 0.126).
Time Course of 2-NBDG Uptake
To analyze the time dependence of 2-NBDG uptake, cells
were incubated with 240 lM of 2-NBDG at 37 C for 0,
2, 5, 10, 20, 40 or 60 min in PBS (no D-glucose) after
applying (or not) electric pulses at 1,000 V/cm. In the
absence of D-glucose and in the absence of pulse delivery,
uptake of 2-NBDG increased in a time-dependent manner
(Fig. 6). It reached a maximum after 60 min of incuba-
tion. In samples exposed to the electric pulses, an increase
in uptake by two orders of magnitude in the part of the
cell population permeabilized by electric pulses was again
observed, even at the maximum incubation time of
60 min (longer times were not tested as cells did not
support longer incubations in the PBS buffer) (Fig. 6).
Changes in fluorescence intensity showed significant dif-
ferences during the different incubation times after the
application of electric pulses (p \ 0.001). At 60 min
electroporation-based uptake (which does not seem to be
modified during the incubation) is completed by the
transport-mediated uptake (which increases during this
time). In addition, there was always a significant differ-
ence in fluorescence intensity between the two experi-
mental groups and between each of the experimental
groups and the control without 2-NBDG (p \ 0.001). This
difference remained significant for up to 60 min of incu-
bation (p \ 0.05).
Time-dependence experiments were also performed in
the presence of 5.5 mM of D-glucose (Fig. 6). Cells were
manipulated under the same conditions except that after
trypsinization they were suspended in modified PBS that
contained 5.5 mM of D-glucose. In the absence of electric
pulses, fluorescence increased regularly with time. Statis-
tical analysis revealed no significant differences between
the uptake of 2-NBDG alone in the presence or in the
absence of D-glucose in all periods examined (2–60 min) in
the absence of electric pulses.
Fig. 3 a Changes in the value of the peak channel of the high-
fluorescence cell population as a function of the pulse field amplitude,
E (in V/cm). b Percentage of highly fluorescent (permeabilized) cells
after incubation with 240 lM 2-NBDG for 10 min at 37 C. Data are
means ± SD of at least three independent experiments
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In the presence of the electric pulses and 5.5 mM
D-glucose, a significant increase in uptake in electroper-
meabilized cells, by about two orders of magnitude, was
again observed, even at 60 min (Fig. 6). Values of fluo-
rescence intensity were similar in the presence and in the
absence of D-glucose, except at 20 or 60 min, when sig-
nificantly higher uptake was recorded in the presence of
D-glucose (p \ 0.05).
2-NBDG Uptake as a Function of Electric Pulses
at 1 Hz and 5 kHz Repetition Frequencies
Finally, the effect of a 5-kHz repetition frequency during
the delivery of the eight electric pulses on 2-NBDG uptake
into electropermeabilized cells was evaluated in compari-
son to the effects of pulses delivered at the usual 1-Hz
repetition frequency. Cells were incubated with 240 lM
2-NBDG for 10 min after applying eight (or no) electric
pulses of 100 ls and 1,000 or 1,200 V/cm at repetition
frequencies of 1 Hz or 5 kHz. In the absence of D-glucose a
difference in uptake by electropermeabilized cells was
indeed found (Fig. 7a). Fluorescence intensity was signif-
icantly higher when pulses were delivered at a repetition
frequency of 1 Hz (p \ 0.001). However, the same data
showed no significant change in the percentage of perme-
abilized cells (p = 0.898) (Fig. 7b).
Fig. 4 Flow cytometric
histograms of DC-3F cells
treated a with no 2-NBDG
(absolute control); b–e with
2-NBDG alone in the presence
of 0, 5.5, 11 or 27.5 mM
D-glucose; and f–i with
2-NBDG and electric pulses
(eight pulses of 100 ls, 1 Hz at
1,000 V/cm) in the presence of
0, 5.5, 11 or 27.5 mM D-
glucose, respectively
Fig. 5 Percentage of highly fluorescent (permeabilized) cells after
exposure of cells to eight pulses of 100 ls and 1,000 V/cm and
incubation with 240 lM 2-NBDG for 10 min at 37 C in the presence
of 0, 5.5, 11 or 27.5 mM of D-glucose. Data are means ± SD of at
least three independent experiments
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As the data also show, there was no significant differ-
ence between 2-NBDG uptake in the absence or the pres-
ence of 5.5 mM D-glucose. Thus, a significant difference
was also found in 2-NBDG uptake after application of
electric pulses at 1-Hz or 5-kHz repetition frequencies in
the presence of 5.5 mM D-glucose (p \ 0.001) (Fig. 7a),
while no significant change was observed in the percentage
of cells permeabilized due to the delivery of electric pulses
at either 1 Hz or 5 kHz (p \ 0.007) (Fig. 7b).
Discussion
We have described for the first time the effect of electric
pulses on the uptake of 2-NBDG (2-[N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino]-2-deoxy-D-glucose), a fluorescent
derivative of D-glucose.
As stated in the Introduction, 2-NBDG is a marker of
glucose uptake in cells of various origins and should have
characteristics similar to those of FDG, which has been
widely used in PET. In spite of high uptake of 2-NBDG by
GLUT transporters into tumor cells, electroporation sig-
nificantly increases 2-NBDG uptake into the tumor cells
used in this study (DC-3F).
Indeed, in the present study, we show that 2-NBDG is
rapidly taken up by, and accumulated in, DC-3F tumor
cells in the absence of electric pulses. Our results are
consistent with previous investigations that have used this
molecule as a fluorescent marker for monitoring glucose
uptake into malignant tumor cells (O’Neil et al. 2005;
Cheng et al. 2006). Because of the aggressive growth
patterns of the tumor cells, uptake of 2-NBDG by tumor
cells is high. However, enhanced accumulation or trapping
of 2-NBDG phosphorylated forms as a result of an increase
of hexokinase activity has also been reported (Flier et al.
1987; Aloj et al. 1999).
Our study demonstrates that, after application of per-
meabilizing electric pulses, uptake of 2-NBDG is actually
increased in the fraction of cells that are electropermeabi-
lized by the electric pulses. The fluorescence of these cells
is about 10–100 times larger than that of cells not exposed
to electric pulses, whatever the experimental conditions
used (with external glucose added or not, for example),
resulting in the reversible electropermeabilization of a
fraction of the treated cells.
In the initial experiments, we determined the experi-
mental conditions. Uptake of 2-NBDG was higher at
37 C, with or without pulses, than at room temperature
Fig. 6 Changes in the peak channel of monodistributed fluorescent
cells not exposed to the electric pulses or changes in the value of the
peak channel of the high-fluorescent cell population after electric
pulse delivery. Cells were incubated in the absence or presence of a
physiological glucose concentration (5.5 mM) for 2–60 min, always
in the presence of 240 lM 2-NBDG and with or without the delivery
of electric pulses (eight pulses of 100 ls, 1 Hz at 1,000 V/cm). Data
are means ± SD of at least three independent experiments. Stars
denote the only values in which a statistically significant difference
was recorded between the absence and the presence of the external
5.5 mM D-glucose. filled square 2-NBDG, filled diamond
2-NBDG ? 5.5 mM D-glucose, filled triangle electric pulses, filled
circle electric pulses ? 5.5 mM D-glucose
Fig. 7 a Changes in the value of the peak channel of the high-
fluorescence cell population. b Percentage of highly fluorescent
(permeabilized) cells after application of electric pulses (eight pulses
of 100 ls, 1 Hz or 5 kHz at 1,000 or 1,200 V/cm). Cells were
incubated for 10 min at 37 C in the absence or presence of
physiological glucose solution (5.5 mM). 1 1,000 V/cm, 2 1,000 V/
cm ? 5.5 mM D-glucose, 3 1,200 V/cm, 4 1,200 V/cm ? 5.5 mM
D-glucose, filled square electric pulses 1 Hz, filled circle electric
pulses 5 kHz
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(22 C). Our results are in agreement with previous studies
showing that in the absence of electric pulses and in the
presence of 600 lM 2-NBDG, uptake into MIN6 cells was
temperature-dependent, the initial velocity of 2-NBDG
uptake at 37 C being twice that at 25 C (Yamada et al.
2000). We then determined that 240 lM 2-NBDG seemed
to be a convenient concentration that results in reproduc-
ible experimental results with the cells used in the present
study. It can be seen in Fig. 2 that the uptake of 2-NBDG
remarkably increased by exposing cells to electric pulses at
all concentrations examined except at the lowest one,
10 lM. Membrane electropermeabilization opened new
ways for the penetration of 2-NBDG inside cells, aside
from its general uptake by the GLUT transporters descri-
bed in the Introduction. This is the reason for the increased
2-NBDG accumulation inside electroporated cells. Con-
trary to facilitated transport, the rate of which is driven
mainly by the number and activity of the transporters
located at the cell surface, uptake through the electropo-
rated membrane is proportional to the external concentra-
tion as clearly shown with typical nonpermeant molecules
(Orlowski et al. 1988; Silve and Mir 2011). The same rule
has been observed with 2-NBDG, the electroporation of the
cell membrane leading to the highest uptake per cell at the
highest concentrations tested, 240 and 300 lM. However,
at 300 lM the percentage of cells in the electropermeabi-
lized fraction slightly decreased, reflecting a potential
toxicity on the electroporated cells of 2-NBDG at the high
internalized concentration in the presence of 300 lM
external 2-NBDG.
As 2-NBDG is normally transported into cells by the
glucose transporters, this uptake should be inhibited by a
high external concentration of unlabeled D-glucose com-
peting with 2-NBDG to interact with the transporters.
Previous studies demonstrated that 2-NBDG uptake was
indeed inhibited in the presence of D-glucose. There is
competition between 2-NBDG and D-glucose for the
facilitated transporters to enter the cell in single vascular
smooth muscle cells (Lloyd et al. 1999), E. coli cells
(Yoshioka et al. 1996a), yeast Candida albicans (Oh et al.
2002) and tumor cells (MCF-7, HepG2, M-1 and U87MG)
(O’Neil et al. 2005; Cheng et al. 2006). Moreover, other
studies have reported that a high external concentration of
D-glucose partially blocks uptake of 2-NBDG in other cells
(Iori et al. 2006). For example, 2-NBDG uptake is inhibited
about 70 % in the presence of 22 mM D-glucose in pan-
creatic ß-cells and 37 and 52 % in the presence of 5.6 and
11.2 mM of D-glucose, respectively (neurons, human
erythrocytes) (Yamada et al. 2000). However, the exact
mechanism of 2-NBDG transport is not known as it has not
been determined whether all six types of glucose trans-
porter can facilitate 2-NBDG uptake or not.
We analyzed the effect of the presence in the medium of
D-glucose on 2-NBDG uptake by DC-3F cells, with or
without electric pulses. Four different concentrations of
D-glucose (0, 5.5, 11 or 27.5 mM) were tested. Competitive
inhibition, increasing with the increased concentration of
the added glucose, was found; but at 5.5 and 11 mM it
affected only some of the cells in the absence of electric
pulses. This result is consistent with previous studies that
reported partial blocking of 2-NBDG uptake at high con-
centrations of D-glucose (Yamada et al. 2000; Iori et al.
2006). Nevertheless, our results are extremely relevant as
the final aim of the study was to analyze whether, by
studying NDBG uptake in vitro, we could determine
whether FDG could be used to image electropermeabilized
tissues in vivo by a technique like PET. Indeed, we show
here that competition between 2-NBDG and glucose is
minimal under physiological conditions (that is, with the
5.5 mM concentration) in the absence of electric pulses and
that in the presence of the electric pulses there is, as
expected, no detectable competition (which is in agreement
with the mechanism of diffusion through the electroper-
meabilized membrane, which is not saturable like transport
through transporters). Moreover, at the different concen-
tration of D-glucose, there was increasing 2-NBDG uptake
into electroporated cells.
The time course of 2-NBDG uptake into DC-3F cells, in
the presence or absence of glucose and with or without
pulse application, was also analyzed. Indeed, in PET
analysis images are taken some minutes after the injection
of FDG into the body. Therefore, it was necessary to
ascertain that the differences observed after 10 min of
incubation (most of the experiments reported) were also
observed for longer incubation times. In the absence of the
electric pulses, our results are in agreement with a study
that measured 10 lM 2-NBDG uptake at 37 C for 0, 15,
30, 60, 120 or 180 min in HepG2 human hepatocarcinoma
cells and L6 rat skeletal muscle cells (Zou et al. 2005).
According to these results, the highest uptake increases
were observed from 0 to 60 min after the beginning of
incubation. Interestingly, the results of this experiment
confirm that in electropermeabilized cells there is no
competition between 2-NBDG and glucose at the physio-
logical concentration (5.5 mM). Moreover, the fluores-
cence taken up by electropermeabilized cells a short time
after the pulse delivery (before the cells reseal) is not lost
during the prolonged incubation of cells, and the difference
from nonpermeabilized cells remains high for all of the
times. As some more uptake can also occur in these cells
after their resealing by the GLUT transporters, as in the
cells not exposed to electric pulses, it is understandable
that the difference is relatively maintained with respect
to nonpermeabilized cells, at least during the 60 min of
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incubation during which changes were followed in the
experiments reported here.
In this study, the effect of the 1-Hz and 5-kHz pulse
frequencies on 2-NBDG uptake into electropermeabilized
cells was also examined. Indeed, the clinical protocols for
electrochemotherapy (Marty et al. 2006; Mir 2006) often
use trains of eight pulses delivered at a repetition frequency
of 5 kHz. This repetition frequency has several advantages.
When pulses are delivered close to muscles, a single
muscle contraction is provoked at 5 kHz instead of eight
muscle contractions when pulses are delivered at 1 Hz.
Moreover, treatment is much faster: the train of pulses
between a pair of electrodes is delivered in 1.5 ms instead
of about 8 s. The results reported here show that, in the
absence of externally added D-glucose, the application of
electric pulses highly increased 2-NBDG uptake with
noticeable differences as a function of the repetition fre-
quency of the electric pulses. Indeed, if the percentage of
electropermeabilized cells is the same at 1-Hz and 5-kHz
pulse frequencies, the fluorescence intensity of the per-
meabilized cells was significantly lower at 5 kHz than at
1 Hz. A study by Pucihar et al. (2002) showed that Lucifer
yellow uptake into the same type of cells (DC-3F) followed
the same trend. Indeed, to maintain the uptake of Lucifer
yellow at the same level, the increase of the repetition
frequency (from 1 Hz to 8.3 kHz) imposed an increase in
the amplitude of the electric pulses applied, which means
that the pulses at the highest repetition frequency were less
efficient at permeabilizing the cells. If we consider that in
our study the effect of the 1-Hz and 5-kHz pulse fre-
quencies was tested at the same amplitude in the absence or
presence of physiological D-glucose, our results are indeed
in agreement with these previous results. It is interesting
that these two markers give the same result as the Lucifer
yellow is a completely nonpermeant molecule, while
2-NBDG would also be a nonpermeant molecule if no
GLUT transporters actively transported it inside the cells.
The reduced effectiveness of the 5-kHz pulses is thus
corroborated by molecules with different behaviors, con-
sidering their ability to cross the plasma membrane.
Simultaneously, these similarities also confirm that the
mechanism of drug uptake in electropermeabilized cells is
diffusion across the permeabilized membranes.
The results of our in vitro studies highlight the ability of
glucose derivatives as markers for monitoring the electrop-
ermeabilization of cells exposed to adequate electric pulses.
Until now, only strictly nonpermeant molecules like Lucifer
Yellow or bleomycin were used as cell electropermeabili-
zation markers (Mir et al. 1998; Pron et al. 1999; Pucihar
et al. 2002; Silve and Mir 2011). As FDG is a radioactive
glucose derivative used for clinical investigations, the
results reported here with 2-NBDG provide a preliminary
step toward in vivo studies of FDG PET imaging in
combination with electroporation. Considering the common
applications of FDG, PET could be a useful means to probe
electroporated cells in vivo, which provides a noninvasive
way to monitor tissue electropermeabilization in living
laboratory animals. FDG PET could then become a very
attractive technique for the accurate detection of electrop-
ermeabilization efficacy in vivo. Further in vivo studies are
thus necessary to assess the potential of this technique.
Conclusions
We investigated the potential of 2-NBDG, a fluorescent
analogue of glucose, to reveal the electropermeabilization
of cells after delivery of electric pulses in vitro. Based on
the results, it can be suggested that FDG PET imaging
could have potential to measure the electropermeabiliza-
tion of cells in vivo.
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